スポーツ栄養の世界市場:製品別(ドリンク、サプリメント、食品)、流通経路別(eコマース、店舗販売)、地域別

◆英語タイトル:Sports Nutrition Market Size, Share & Trends Analysis Report By Product (Drinks, Supplements, Foods), By Distribution Channel (Ecommerce, Bricks & Mortar), By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY074
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年2月28日
◆ページ数:160
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、スポーツ栄養の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別(ドリンク、サプリメント、食品)分析、流通経路別(eコマース、店舗販売)分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・スポーツ栄養の世界市場:製品別(ドリンク、サプリメント、食品)
・スポーツ栄養の世界市場:流通経路別(eコマース、店舗販売)
・スポーツ栄養の世界市場:地域別
・競争状況
【レポートの概要】

The global sports nutrition market size is expected to reach USD 31.0 billion by 2027, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing importance of an active lifestyle owing to rise in sedentary jobs and shift in demographic base from core athletes to recreational athletes and lifestyle users are the key factors expected to drive the market. Moreover, increasing number of health and fitness centers and gyms, rising consumer awareness regarding the adoption of a healthy lifestyle, and demand for these products from athletes is expected to boost the market growth.

Widespread product availability due to the presence of large companies is expected to drive the demand for these products. For instance, in 2018, Amazon launched its private label sports supplement brand “OWN PWR” for U.S. consumers. Companies such as Glanbia Plc; Abbott Laboratories Inc.; Neutra Science Labs; Hormel Foods Corporation; and GNC Corporation are the key players operating in the market. Moreover, favorable government initiatives to promote health, growing base of health-conscious population, and rising awareness about sedentary health risks further drive the market.

Moreover, the U.S. population is becoming increasingly health-conscious and hence focuses on adopting an active lifestyle. The International Health, Racquet & Sportsclub Association (IHRSA), a Boston-based, commercial health clubs trade association, reported a 3.6% rise in the number of health club members, from 55.3 million in 2015 to 57.3 million in 2016. The number of health clubs in U.S. increased by 5.2%, from 36,540 in 2016 to 38,447 in 2017. These health clubs and fitness centers have consulting dietitians, which influences the consumption of sports nutrition products among trainers and fitness enthusiasts.

Further key findings from the report suggest:

• Sports supplements emerged as the largest product segment in 2019 with a share of over 80.0% of the global sports nutrition market owing to increasing commercialization of these supplements and wide product range including creatine and whey protein supplements

• On the basis of distribution channel, bricks and mortar dominated the market in 2019 owing to high consumer base for retail stores

• Ecommerce is projected to be the fastest-growing segment over the forecast period owing to increasing popularity of ecommerce platforms and the associated benefits such as discounts and convenience

• North America dominated the global market in 2019 due to growing awareness about nutritional supplements and rise in government initiatives promoting sports-related activities

• Key players operating in the market include Glanbia plc; Hormel Foods Corporation; General Nutrition Centers, Inc.;Abbott; The Coca-Cola Company; and Clif Bar & Company.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Sports Nutrition Snapshot
Chapter 3 Global Sports Nutrition Market Variables, Trends, & Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.3 Industry Challenges
3.3 Global Sports Nutrition Market Analysis Tools
3.3.1 Industry Analysis – Porter’s
3.3.1.1 Bargaining power of the suppliers
3.3.1.2 Bargaining power of the buyers
3.3.1.3 Threats of substitution
3.3.1.4 Threats from new entrants
3.3.1.5 Competitive rivalry
3.3.2 PESTEL Analysis
3.3.2.1 Political landscape
3.3.2.2 Economic and Social landscape
3.3.2.3 Technology landscape
3.3.2.4 Legal landscape
3.3.2.5 Technology landscape
Chapter 4 Sports Nutrition Market: Product Type Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Global Sports Nutrition Market: Product Market Share Analysis, 2019 and 2027
4.3 Sports drinks
4.3.1 Sports drinks analysis market estimates and forecasts, 2016-2027 (USD million)
4.4 Sports supplements
4.4.1 Sports supplements analysis market estimates and forecasts, 2016-2027 (USD million)
4.5 Sports food
4.5.1 Sports food analysis market estimates and forecasts, 2016-2027 (USD million)
Chapter 5 Sports Nutrition Market: Distribution Channel Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Sports Nutrition Market: Distribution Channel Market Share Analysis, 2019 and 2027
5.3 E-commerce
5.3.1 E-commerce analysis market estimates and forecasts, 2016-2027 (USD million)
5.4 Bricks and mortar
5.4.1 Bricks and mortar analysis market estimates and forecasts, 2016-2027 (USD million)
Chapter 6 Sports Nutrition Market: Regional Estimates & Trend Analysis, By Product and Distribution Channel
6.1 Global Sports Nutrition Market: Regional Movement Analysis
6.2 North America
6.2.1 North America sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.2.3 Canada
6.2.3.1 Canada sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3 Europe
6.3.1 Europe sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.3 Germany
6.3.3.1 Germany sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.4 France
6.3.4.1 France sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.5 Italy
6.3.5.1 Italy sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.6 Spain
6.3.6.1 Spain sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.2 Japan
6.4.2.1 Japan sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.3 China
6.4.3.1 China sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.4 India
6.4.4.1 India sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.5 Australia
6.4.5.1 Australia sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.6 New Zealand
6.4.6.1 New Zealand sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5 Latin America
6.5.1 Latin America sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6 MEA
6.6.1 MEA sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.4 UAE
6.6.4.1 UAE sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.2 Company Profiles
7.3 Glanbia Plc
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 AirStrip Technologies
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Hormel Foods Corporation
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 General Nutrition Centers, Inc.
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 Abbott
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic Initiatives
7.8 Science in Sport
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 The Hut Group
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic Initiatives
7.10 Iovate Health Sciences International Inc.
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic Initiatives
7.11 Cardiff Sports Nutrition LTD.
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic Initiatives
7.12 Clif Bar & Company
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic Initiatives
7.13 MUSCLEPHARM
7.13.1 Company overview
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic Initiatives
7.14 Nature’s Bounty
7.14.1 Company overview
7.14.2 Financial performance
7.14.3 Product benchmarking
7.14.4 Strategic Initiatives
7.15 POST HOLDINGS, INC.
7.15.1 Company overview
7.15.2 Financial performance
7.15.3 Product benchmarking
7.15.4 Strategic Initiatives

List of Tables

TABLE 1 Ongoing projects for CAR T-cell therapies
TABLE 2 Non-viral DNA vectors (non-replicating) in gene therapy trials
TABLE 3 Some of the examples of molecules under development based on lentiviral vectors
TABLE 4 Molecules in development based on AAV vectors
TABLE 5 North America gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 6 North America gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 7 U.S. gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 8 U.S. gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 9 Canada gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 10 Canada gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 11 Europe gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 12 Europe gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 13 Asia Pacific gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 14 Asia Pacific gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 15 China gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 16 China gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 17 Japan gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 18 Japan gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 19 Russia gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 20 Russia gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 21 Australia gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 22 Australia gene therapy market, by vector type, 2016 - 2027 (USD Million)


List of Figures

FIG. 1 Market summary (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global gene therapy pipeline as of 2017, by phase of trial
FIG. 12 Global cancer incidence, as of September 2018
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Gene therapy prices by eligible patients per year
FIG. 15 Annual Investment in the CAR-T Space, 2013 - 2026
FIG. 16 Global financings in cell therapy, 2016-2018
FIG. 17 Recent and ongoing manufacturing capacity expansions for viral vector and large-scale cell therapies, as of 2017
FIG. 18 SWOT Analysis, By Factor (Political & legal, economic and technological)
FIG. 19 Porter’s Five Forces Analysis
FIG. 20 Gene therapy market: Indication outlook key takeaways
FIG. 21 Gene therapy market: Indication movement analysis
FIG. 22 Global gene therapy market for Acute Lymphoblastic Leukemia (ALL), 2016 - 2027 (USD Million)
FIG. 23 Global gene therapy market for inherited retinal disease, 2016 - 2027 (USD Million)
FIG. 24 Global gene therapy market for large B-cell lymphoma, 2016 - 2027 (USD Million)
FIG. 25 Global gene therapy market for ADA-SCID, 2016 - 2027 (USD Million)
FIG. 26 Global gene therapy market for melanoma (lesions), 2016 - 2027 (USD Million)
FIG. 27 Global gene therapy market for Beta-Thalassemia Major/SCD, 2016 - 2027 (USD Million)
FIG. 28 Global gene therapy market for head & neck squamous cell carcinoma, 2016 - 2027 (USD Million)
FIG. 29 Global gene therapy market for peripheral arterial disease, 2016 - 2027 (USD Million)
FIG. 30 Global gene therapy market for Spinal Muscular Atrophy (SMA), 2016 - 2027 (USD Million)
FIG. 31 Global gene therapy market for other indications, 2016 - 2027 (USD Million)
FIG. 32 Gene therapy market vector type outlook: Key takeaways
FIG. 33 Gene therapy market: Vector type movement analysis
FIG. 34 Global lentivirus-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 35 Global AAV-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 36 Global retrovirus and gammaretrovirus vector-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 37 Global modified herpes simplex virus vectors-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 38 Global adenovirus vectors-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 39 Global non-viral plasmid vector-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 40 Regional market place: Key takeaways
FIG. 41 Stem cells & non-stem cells regional outlook, 2019 & 2027
FIG. 42 North America gene therapy market, 2016 - 2027 (USD Million)
FIG. 43 U.S. gene therapy market, 2016 - 2027 (USD Million)
FIG. 44 Canada gene therapy market, 2016 - 2027 (USD Million)
FIG. 45 Europe gene therapy market, 2016 - 2027 (USD Million)
FIG. 46 Asia Pacific gene therapy market, 2016 - 2027 (USD Million)
FIG. 47 China gene therapy market, 2016 - 2027 (USD Million)
FIG. 48 Japan gene therapy market, 2016 - 2027 (USD Million)
FIG. 49 Russia gene therapy market, 2016 - 2027 (USD Million)
FIG. 50 Australia gene therapy market, 2016 - 2027 (USD Million)
FIG. 51 Strategy framework

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[スポーツ栄養の世界市場:製品別(ドリンク、サプリメント、食品)、流通経路別(eコマース、店舗販売)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆